Smart patch could spot chemo side effects early
NCT ID NCT06657183
First seen May 17, 2026 · Last updated May 18, 2026 · Updated 1 time
Summary
This study tests a wearable smart patch that continuously tracks vital signs and glucose levels in 30 cancer patients receiving chemotherapy or immunotherapy. The goal is to detect side effects like febrile neutropenia sooner, so treatment can be adjusted quickly. Participants wear the patch and a glucose monitor, with a remote care team watching the data 24/7.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FEBRILE NEUTROPENIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Case Comprehensive Cancer Center, University Hospitals Cleveland Medical Center Seidman Cancer Center
RECRUITINGCleveland, Ohio, 44106, United States
Contact
Conditions
Explore the condition pages connected to this study.